A Study of M701 (EpCAM and CD3) in Malignant Ascites (Q113891271)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of M701 (EpCAM and CD3) in Malignant Ascites |
clinical trial |
Statements
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability and PK/PD of Recombinant Anti-EpCAM and Anti-CD3 Human-Mouse Chimeric Bispecific Antibody Via Intraperitoneal Infusion in Malignant Ascites (English)
0 references
30 October 2018
0 references
31 January 2021
0 references
42
0 references
18 year
0 references